Pharmadrug Inc (PHRX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | -9 | 6 | 11 | 315 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -90 |
| Accounts receivable | 14 | 14 | 73 | -135 | -52 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 282 | N/A |
| Other Working Capital | 102 | 266 | 108 | 247 | 70 |
| Other Operating Activity | -207 | -335 | -509 | -1,025 | -1,496 |
| Operating Cash Flow | $-92 | $-64 | $-322 | $-619 | $-1,252 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 0 | -2 |
| Net Acquisitions | N/A | 0 | 3 | 0 | 0 |
| Sale Of Investment | 208 | 94 | 0 | 0 | 0 |
| Other Investing Activity | 0 | 0 | 0 | -3 | 0 |
| Investing Cash Flow | $208 | $94 | $3 | $-3 | $-2 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -96 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 0 | 650 | 2 | N/A |
| Debt Repayment | 0 | 0 | -2 | 0 | -16 |
| Common Stock Issued | N/A | 0 | 0 | 280 | N/A |
| Other Financing Activity | -21 | -68 | -81 | 79 | 0 |
| Financing Cash Flow | $-117 | $-68 | $567 | $361 | $-16 |
| Exchange Rate Effect | 1 | 18 | -240 | 219 | 390 |
| Beginning Cash Position | 9 | 28 | 19 | 77 | 958 |
| End Cash Position | 8 | 9 | 28 | 19 | 77 |
| Net Cash Flow | $-1 | $-38 | $249 | $-261 | $-1,270 |
| Free Cash Flow | |||||
| Operating Cash Flow | -92 | -64 | -322 | -619 | -1,252 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -2 |
| Free Cash Flow | -92 | -64 | -322 | -619 | -1,254 |